High expression of 14‑3‑3ơ indicates poor prognosis and progression of lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High expression of 14‑3‑3ơ indicates poor prognosis and progression of lung adenocarcinoma

Published:2022-05-12 Issue:1 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Feng Junfei¹,Leng Jing¹,Zhao Changdi¹,Guo Jie¹,Chen Yongbing²,Li Haifeng¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, The Third People's Hospital of Yunnan Province, Kunming, Yunnan 650011, P.R. China

2. Department of Respiratory Medicine, People's Hospital of Beilun District, Ningbo, Zhejiang 315826, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference51 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents;Robinson;Oncologist,2013

3. Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy;Kobayashi;Cancer Sci,2016

4. Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer;Karachaliou;Expert Opin Investig Drugs,2017

5. The distinctive nature of adenocarcinoma of the lung;Roviello;Onco Targets Ther,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP